Qynapse Email Formats

Medical Equipment Manufacturing • Paris, Île-de-France, France • 21-50 Employees

Qynapse Email Formats

Qynapse uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@qynapse.com), used 39.1% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@qynapse.com	39.1%
{first name}{last name}	johndoe@qynapse.com	34.8%
{first initial}	j@qynapse.com	8.7%
{first initial}.{last name}	j.doe@qynapse.com	8.7%
{first name}.{last name}	john.doe@qynapse.com	4.3%

Key Contact at Qynapse

Perrine Dellong

Quality And Regulatory Affairs Director

Company overview

Headquarters	130 rue de Lourmel, Paris, 75015, FR
Website	qynapse.com
NAICS	3391
SIC	737
Keywords	Medical Device, Personalized Medicine, Clinical Trials, Drug Safety, Dementia, Psychiatry, Neurology, Diagnosis, Monitoring, Clinical Research, Artificial Intelligence, Multiple Sclerosis, Central Nervous System, Azheimer'S, Stroke, Prediction, Neuroimaging, Parkinson'S, Drug Efficacy, Disease Trajectory
Founded	2015
Employees	21-50
Socials

About Qynapse

The future of neuroimaging analysis is here and Qynapse is leading the way. For clinicians on the front lines, for patients and their families, for payers, and for pharma – we offer peace of mind by providing results you can trust. Headquartered in France, in the United States and in Canada, the Qynapse team, with our world-renowned team of scientific and clinical partners, is wholly dedicated to aspiring to bring the entire neuroscience community and their patients the clearest, most accurate and reliable predictors and objective measures of devastating CNS disorders such as Alzheimer's disease, multiple sclerosis and Parkinson’s disease. We are constantly evolving, refining and testing our FDA-cleared and CE-marked neuroimaging software platform, QyScore®, which is powered by proprietary Artificial Intelligence, to provide physicians, pharma researchers and payers a reliable layer of precision when reading an MRI scan. QyPredict®, our predictive research-use-only platform powered by machine learning algorithms, is being designed to transform what we know about CNS disease trajectory, with the potential to dramatically increase the likelihood of a successful clinical trial. Together, we are moving forward to a brighter and more accurate future of diagnosis and treatment for central nervous system diseases.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Head

Employees by Department

Qynapse has 16 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Qynapse's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-07-24	3	$3,000,000

Funding Insights

$3,000,000

Total funding amount

$3,000,000

Most recent funding amount

Number of funding rounds

Qynapse Tech Stack

Discover the technologies and tools that power Qynapse's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

reCAPTCHA

Security

Gravity Forms

Form builders

Amazon SES

Swiper

JavaScript libraries

jQuery UI

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

HSTS

Security

WordPress

Blogs

Frequently asked questions

Qynapse is located in Paris, Île-de-France, FR.

Qynapse was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

Qynapse has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Qynapse has raised a total of $3,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Qynapse

Perrine Dellong

Quality And Regulatory Affairs Director

4.8

40,000 users